Please enable JavaScript to continue using this application.

Compare $RNA vs $TNYA | Chartloom

Compare

$RNA vs $TNYA

Atrium Therapeutics Inc · Tenaya Therapeutics Inc

RNA

Atrium Therapeutics Inc

TNYA

Tenaya Therapeutics Inc

Compare $RNA vs $TNYA

Comparing Atrium Therapeutics Inc and Tenaya Therapeutics Inc

RNAAtrium Therapeutics Inc

TNYATenaya Therapeutics Inc

RNAAtrium Therapeutics Inc

Market cap

$144M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

22.0%

YTD performance

-88.3%

52W performance

-82.6%

FCF yield

-55.5%

TNYATenaya Therapeutics Inc

Market cap

$126M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

20.11x

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

-68.3%

FCF yield

-41.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RNA

TNYA

Detailed metrics comparison

RNA

Atrium Therapeutics Inc

TNYA

Tenaya Therapeutics Inc

Market Cap

RNA$144M

TNYA$126M

Enterprise Value

RNA$71M

TNYA$48M

Price

RNA$8.40

TNYA$0.58

P/E Ratio

RNAN/A

TNYAN/A

P/S Ratio

RNA3.48x

TNYA94.33x

EV/Sales

RNA1.73x

TNYA35.84x

EV/EBITDA

RNA0.00x

TNYA0.00x

P/B Ratio

RNA0.63x

TNYA1.82x

P/FCF Ratio

RNAN/A

TNYAN/A

EV/FCF

RNA-0.89x

TNYA-0.91x

PEG Ratio

RNAN/A

TNYAN/A

Forward P/E (NTM)

RNAN/A

TNYAN/A

Forward P/S (NTM)

RNAN/A

TNYA20.11x

Revenue (TTM)

RNA$41M

TNYA$1M

Revenue Growth (YoY)

RNA22.0%

TNYAN/A

Forward Rev Growth

RNA-94.2%

TNYA-49.9%

Gross Margin (TTM)

RNA0.0%

TNYA0.0%

Operating Margin (TTM)

RNA0.0%

TNYA0.0%

EBITDA Margin (TTM)

RNA-215.0%

TNYA-5657.2%

Net Margin (TTM)

RNA-209.2%

TNYA-7724.0%

FCF Margin (TTM)

RNA-193.4%

TNYA-3939.2%

Net Income (TTM)

RNA$-86M

TNYA$-103M

FCF (TTM)

RNA$-80M

TNYA$-53M

EPS (TTM)

RNA-$5.05

TNYA-$0.47

ROE (TTM)

RNA-4030.0%

TNYA-10805.0%

ROA (TTM)

RNA-5864.0%

TNYA-8584.0%

ROIC (TTM)

RNA-4433.7%

TNYA-10805.0%

Cash

RNA$72M

TNYA$78M

Debt

RNA$0

TNYA$0

Net Cash/Debt

RNA$72M

TNYA$78M

Current Ratio (TTM)

RNA8.73x

TNYA4.52x

Quick Ratio (TTM)

RNA8.59x

TNYA4.34x

Debt/Equity (TTM)

RNA0.00x

TNYA0.00x

Debt/Assets (TTM)

RNA0.0%

TNYA0.0%

Interest Coverage (TTM)

RNAN/A

TNYAN/A

Net Debt/EBITDA (TTM)

RNA0.00x

TNYA0.00x

Beta

RNA1.20

TNYA2.87

52W Performance

RNA-82.6%

TNYA-68.3%

YTD Performance

RNA-88.3%

TNYA-21.0%

% from 52W High

RNA-88.5%

TNYA-75.3%

% from 52W Low

RNA10.1%

TNYA11.4%

Asset Turnover (TTM)

RNA0.28x

TNYA0.00x

FCF Yield (TTM)

RNA-55.5%

TNYA-41.8%

Earnings Yield (TTM)

RNA-60.1%

TNYA-81.9%

Dividend Yield (TTM)

RNAN/A

TNYAN/A

Rule of 40

RNA-171.3

TNYA-3,939.2

EV/GP/RG

RNAN/A

TNYAN/A

Ticker research

View RNA research View TNYA research

Metric	RNA Atrium Therapeutics Inc	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$144M	$126M
Enterprise Value	$71M	$48M
Price	$8.40	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	3.48x	94.33x
EV/Sales	1.73x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.63x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.89x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	20.11x
Revenue & Growth
Revenue (TTM)	$41M	$1M
Revenue Growth (YoY)	22.0%	N/A
Forward Rev Growth	-94.2%	-49.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-215.0%	-5657.2%
Net Margin (TTM)	-209.2%	-7724.0%
FCF Margin (TTM)	-193.4%	-3939.2%
Net Income (TTM)	$-86M	$-103M
FCF (TTM)	$-80M	$-53M
EPS (TTM)	-$5.05	-$0.47
ROE (TTM)	-4030.0%	-10805.0%
ROA (TTM)	-5864.0%	-8584.0%
ROIC (TTM)	-4433.7%	-10805.0%
Financial Health
Cash	$72M	$78M
Debt	$0	$0
Net Cash/Debt	$72M	$78M
Current Ratio (TTM)	8.73x	4.52x
Quick Ratio (TTM)	8.59x	4.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	2.87
52W Performance	-82.6%	-68.3%
YTD Performance	-88.3%	-21.0%
% from 52W High	-88.5%	-75.3%
% from 52W Low	10.1%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.00x
FCF Yield (TTM)	-55.5%	-41.8%
Earnings Yield (TTM)	-60.1%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-171.3	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View RNA research	View TNYA research

Valuation

P/S Ratio

RNA

3.48x

TNYA

94.33x

EV/FCF

TNYA

-0.91x

RNA

-0.89x

Growth & revenue

Revenue Growth TTM

RNA

22.0%

Forward Revenue Growth

TNYA

-49.9%

RNA

-94.2%

Profitability & performance

Gross Margin

RNA

0.0%

TNYA

0.0%

ROE

RNA

-4030.0%

TNYA

-10805.0%

FCF Yield %

TNYA

-41.8%

RNA

-55.5%

52-Week Performance

TNYA

-68.3%

RNA

-82.6%

Detailed metrics comparison

RNA

Atrium Therapeutics Inc

TNYA

Tenaya Therapeutics Inc

Market Cap

RNA$144M

TNYA$126M

Enterprise Value

RNA$71M

TNYA$48M

Price

RNA$8.40

TNYA$0.58

P/E Ratio

RNAN/A

TNYAN/A

P/S Ratio

RNA3.48x

TNYA94.33x

EV/Sales

RNA1.73x

TNYA35.84x

EV/EBITDA

RNA0.00x

TNYA0.00x

P/B Ratio

RNA0.63x

TNYA1.82x

P/FCF Ratio

RNAN/A

TNYAN/A

EV/FCF

RNA-0.89x

TNYA-0.91x

PEG Ratio

RNAN/A

TNYAN/A

Forward P/E (NTM)

RNAN/A

TNYAN/A

Forward P/S (NTM)

RNAN/A

TNYA20.11x

Revenue (TTM)

RNA$41M

TNYA$1M

Revenue Growth (YoY)

RNA22.0%

TNYAN/A

Forward Rev Growth

RNA-94.2%

TNYA-49.9%

Gross Margin (TTM)

RNA0.0%

TNYA0.0%

Operating Margin (TTM)

RNA0.0%

TNYA0.0%

EBITDA Margin (TTM)

RNA-215.0%

TNYA-5657.2%

Net Margin (TTM)

RNA-209.2%

TNYA-7724.0%

FCF Margin (TTM)

RNA-193.4%

TNYA-3939.2%

Net Income (TTM)

RNA$-86M

TNYA$-103M

FCF (TTM)

RNA$-80M

TNYA$-53M

EPS (TTM)

RNA-$5.05

TNYA-$0.47

ROE (TTM)

RNA-4030.0%

TNYA-10805.0%

ROA (TTM)

RNA-5864.0%

TNYA-8584.0%

ROIC (TTM)

RNA-4433.7%

TNYA-10805.0%

Cash

RNA$72M

TNYA$78M

Debt

RNA$0

TNYA$0

Net Cash/Debt

RNA$72M

TNYA$78M

Current Ratio (TTM)

RNA8.73x

TNYA4.52x

Quick Ratio (TTM)

RNA8.59x

TNYA4.34x

Debt/Equity (TTM)

RNA0.00x

TNYA0.00x

Debt/Assets (TTM)

RNA0.0%

TNYA0.0%

Interest Coverage (TTM)

RNAN/A

TNYAN/A

Net Debt/EBITDA (TTM)

RNA0.00x

TNYA0.00x

Beta

RNA1.20

TNYA2.87

52W Performance

RNA-82.6%

TNYA-68.3%

YTD Performance

RNA-88.3%

TNYA-21.0%

% from 52W High

RNA-88.5%

TNYA-75.3%

% from 52W Low

RNA10.1%

TNYA11.4%

Asset Turnover (TTM)

RNA0.28x

TNYA0.00x

FCF Yield (TTM)

RNA-55.5%

TNYA-41.8%

Earnings Yield (TTM)

RNA-60.1%

TNYA-81.9%

Dividend Yield (TTM)

RNAN/A

TNYAN/A

Rule of 40

RNA-171.3

TNYA-3,939.2

EV/GP/RG

RNAN/A

TNYAN/A

Ticker research

View RNA research View TNYA research

Metric	RNA Atrium Therapeutics Inc	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$144M	$126M
Enterprise Value	$71M	$48M
Price	$8.40	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	3.48x	94.33x
EV/Sales	1.73x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.63x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.89x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	20.11x
Revenue & Growth
Revenue (TTM)	$41M	$1M
Revenue Growth (YoY)	22.0%	N/A
Forward Rev Growth	-94.2%	-49.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-215.0%	-5657.2%
Net Margin (TTM)	-209.2%	-7724.0%
FCF Margin (TTM)	-193.4%	-3939.2%
Net Income (TTM)	$-86M	$-103M
FCF (TTM)	$-80M	$-53M
EPS (TTM)	-$5.05	-$0.47
ROE (TTM)	-4030.0%	-10805.0%
ROA (TTM)	-5864.0%	-8584.0%
ROIC (TTM)	-4433.7%	-10805.0%
Financial Health
Cash	$72M	$78M
Debt	$0	$0
Net Cash/Debt	$72M	$78M
Current Ratio (TTM)	8.73x	4.52x
Quick Ratio (TTM)	8.59x	4.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.20	2.87
52W Performance	-82.6%	-68.3%
YTD Performance	-88.3%	-21.0%
% from 52W High	-88.5%	-75.3%
% from 52W Low	10.1%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.28x	0.00x
FCF Yield (TTM)	-55.5%	-41.8%
Earnings Yield (TTM)	-60.1%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-171.3	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View RNA research	View TNYA research